Review decision – March 2017
Review of NICE Diagnostics Guidance No. DG9; EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer: review decision
Decision to move the existing guidance to the static list.
We were proposing to transfer the guidance to the static list. During consultation, the majority of comments received from stakeholders agreed with the proposal put forward. After consideration of all of the comments, the NICE Guidance Executive has approved this decision.
This page was last updated: